JP2023519199A5 - - Google Patents

Info

Publication number
JP2023519199A5
JP2023519199A5 JP2022556050A JP2022556050A JP2023519199A5 JP 2023519199 A5 JP2023519199 A5 JP 2023519199A5 JP 2022556050 A JP2022556050 A JP 2022556050A JP 2022556050 A JP2022556050 A JP 2022556050A JP 2023519199 A5 JP2023519199 A5 JP 2023519199A5
Authority
JP
Japan
Prior art keywords
pharmaceutical preparation
pharmaceutical formulation
group
pharmaceutical
pulmonary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022556050A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023519199A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/024077 external-priority patent/WO2021195328A1/en
Publication of JP2023519199A publication Critical patent/JP2023519199A/ja
Publication of JP2023519199A5 publication Critical patent/JP2023519199A5/ja
Pending legal-status Critical Current

Links

JP2022556050A 2020-03-25 2021-03-25 トレプロスチニルプロドラッグの医薬製剤及びその使用方法 Pending JP2023519199A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062994596P 2020-03-25 2020-03-25
US62/994,596 2020-03-25
PCT/US2021/024077 WO2021195328A1 (en) 2020-03-25 2021-03-25 Pharmaceutical formulations of treprostinil prodrugs and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2023519199A JP2023519199A (ja) 2023-05-10
JP2023519199A5 true JP2023519199A5 (https=) 2024-03-14

Family

ID=77892300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022556050A Pending JP2023519199A (ja) 2020-03-25 2021-03-25 トレプロスチニルプロドラッグの医薬製剤及びその使用方法

Country Status (4)

Country Link
US (1) US20240238309A1 (https=)
EP (1) EP4126856A4 (https=)
JP (1) JP2023519199A (https=)
WO (1) WO2021195328A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2860975T3 (es) 2013-10-25 2021-10-05 Insmed Inc Compuestos de prostaciclina
CN114072136B (zh) 2019-04-29 2024-11-29 英斯梅德股份有限公司 曲前列素前药的干粉组合物及其使用方法
WO2022094100A1 (en) * 2020-10-28 2022-05-05 Insmed Incorporated Dry powder compositions of treprostinil prodrugs and methods of use thereof
CN121001747A (zh) * 2023-04-03 2025-11-21 菲沃瑞特制药 治疗转移性癌症和其他癌症的药物组合物和方法
WO2025147662A1 (en) * 2024-01-04 2025-07-10 Insmed Incorporated Methods of treatment using dry powder compositions of treprostinil prodrugs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2234266T3 (es) * 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
JP4672143B2 (ja) * 1998-08-04 2011-04-20 ヤゴテック アーゲー 医薬用エーロゾル製剤
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
TWI399202B (zh) * 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
ES2860975T3 (es) * 2013-10-25 2021-10-05 Insmed Inc Compuestos de prostaciclina
WO2015138423A1 (en) * 2014-03-11 2015-09-17 Insmed Incorporated Prostacylin compositions and methods for using the same
CN114652704A (zh) * 2022-04-29 2022-06-24 兆科药业（广州）有限公司 一种曲前列尼尔软雾吸入剂

Similar Documents

Publication Publication Date Title
JP2023519199A5 (https=)
JP4612956B2 (ja) 抗コリン作用化合物及びβ−擬似剤に基づく新規医薬組成物
CN1822817B (zh) 用于治疗肺性高血压的可吸入制剂及其使用方法
ES2779273T3 (es) Formulación superfina de formoterol
US7611694B2 (en) Aerosol formulation for inhalation comprising an anticholinergic
JP2019528320A5 (https=)
CA2495275C (en) Aerosol formulation for inhalation comprising an anticholinergic agent
JP2022530637A5 (https=)
CA3028731A1 (en) Compositions, devices, and methods for the treatment of alcohol use disorder
RU2013155903A (ru) Композиции, способы и устройства для респираторной доставки двух или более активных средств
ES2533535T3 (es) Soluciones para inhalación
JP2019531308A5 (https=)
CA2420532A1 (en) Pharmaceutical formulation of salmeterol and fluticasone propionate
KR20140003504A (ko) 항 무스카린성 약물을 포함하는 액체의 분사제 비함유 제제
Pavia et al. Preliminary data from phase II studies with Respimat, a propellant-free soft mist inhaler
US20080280897A1 (en) Aerosol Formulation for Inhalation
US6515022B2 (en) Use of inhaled retinoids in the treatment of lung diseases
WO2020019953A1 (zh) 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用
US20210205223A1 (en) Propellant-free formulation for inhalation
WO2024054226A1 (en) Gallium nitrate and dimethyl sulfoxide composition for respiratory treatment
HK1093017B (en) Inhalable formulations for treating pulmonary hypertension and methods of using same
HK1176290B (en) Inhalation solutions